Topics:
Clinical pharmacology
22/03/2004 00:00:00
Current versions available to download
Current translated versions available to download:
Authors
J. Lopez-Sendon FESC (Chairperson), K. Swedberg FESC, J. McMurray FESC, J. Tamargo FESC, A. P. Maggioni FESC, H. Dargie FESC, M. Tendera FESC, F. Waagstein FESC, J. Kjekshus FESC, P. Lechat FESC, C. Torp-Pedersen FESC
Endorsed by:
Table of contents: Full Text (ESC Clinical Practice Guidelines)
Pharmacology
- Definition
- ACE-inhibitor classification
- Pharmacokinetic profile
- Mechanism of action
- Effects of ACE-inhibitors: Haemodynamic effects, Neurohormonal effects, Antiproliferative effects, Renal effects, Other effects, Effects on fibrinolytic balance
- Side effects
- Contraindications
- Drug interactions
- Dosing
Clinical efficacy and practical use
- Heart failure: Target dose, ACE-I compared with angiotensin, receptor blockers
- Asymptomatic left ventricular systolic dysfunction, Diastolic failure
- Acute myocardial infarction
- Hypertension
- Secondary prevention and high-risk of cardiovascular disease
- Prevention of sudden cardiac death
Previous versions
A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here